Google
Apple
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Italiano
Nederlands (Nederland)
Nederlands (België)
LONZA GROUP AG |
Delayed
Other stock markets
|
|
5-day change | 1st Jan Change | |
| 425.60 CHF | +0.83% | -0.16% | -6.07% | |
| Sep. 28 | AlphaValue/Baader Europe Lowers Price Target on Lonza Group, Maintains Buy Recommendation | MT |
| Sep. 21 | Swiss Pharmaceutical Manufacturing Group Lonza Reiterates FY23 Outlook | MT |
Chart calendar Lonza Group AG
94296d4d0397b94748d761a.VreycOdvS3QBJ8kmntHiqrz1YpbuFHvdv_e8JE1ZrK8.INDRBt42ehNlUvxAxKun6NO9E9e0fxmFioPuF2A_3JoC8IRE0i0zQlNAug~61b9f6fe4c336ea83532ba035fe746de
Upcoming events on Lonza Group AG
Past events on Lonza Group AG
| 2023-07-21 08:00 am | Q2 2023 Earnings Call |
| 2023-07-21 01:00 am | Q2 2023 Earnings Release |
| 2023-05-08 | Détachement de for final dividend |
| 2023-05-08 | Détachement de for Distribution from share premium account |
| 2023-05-05 04:00 am | Annual General Meeting |
| 2023-01-25 08:00 am | FY 2022 Earnings Call |
| 2023-01-24 | FY 2022 Earnings Release |
| 2023-01-11 01:30 pm | JP Morgan Healthcare Conference |
| 2022-09-27 | Citi European HC Bus Tour |
| 2022-09-14 | Roadshow |
| 2022-09-13 | Roadshow |
| 2022-09-01 | Roadshow |
| 2022-08-30 | Roadshow - Day 2 |
| 2022-08-29 | Roadshow - Day 1 |
| 2022-07-22 08:00 am | Interim 2022 Earnings Call |
| 2022-07-21 | Interim 2022 Earnings Release |
| 2022-05-08 | Détachement de for final dividend |
| 2022-05-08 | Détachement de for Distribution from share premium account |
| 2022-05-05 04:00 am | Annual General Meeting |
| 2022-01-26 08:00 am | FY 2021 Earnings Call |
Past dividends on Lonza Group AG
| 2023-05-08 | Annual 1.75 CHF |
| 2023-05-08 | 1.75 CHF |
| 2022-05-08 | Annual 1.5 CHF |
| 2022-05-08 | 1.5 CHF |
| 2021-05-09 | 1.5 CHF |
| 2021-05-09 | Annual 1.5 CHF |
| 2020-04-29 | 1.375 CHF |
| 2020-04-29 | Annual 1.375 CHF |
| 2019-04-23 | 2.75 CHF |
| 2018-05-07 | 2.75 CHF |
Annual results
| Fiscal Period | December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|
|
Net sales Million CHF | Released Forecast Spread | 5 542 5 872 -5.62% | 5 920 5 897 0.4% | 6 185 6 161 0.39% | 5 409 5 187 4.28% | 6 223 6 189 0.55% | 6 413 |
|
EBITDA Million CHF | Released Forecast Spread | 1 511 1 529 -1.17% | 1 624 1 615 0.57% | 1 728 1 696 1.91% | 1 665 1 654 0.66% | 1 995 1 936 3.03% | 1 834 |
|
EBIT Million CHF | Released Forecast Spread | 1 165 1 176 -0.98% | 1 249 1 218 2.58% | 1 358 1 310 3.65% | 1 151 1 184 -2.79% | 1 397 1 372 1.85% | 1 202 |
|
Earnings before Tax (EBT) Million CHF | Released Forecast Spread | 807 819 -1.46% | 849 885 -4.04% | 986 981 0.51% | 760 847 -10.23% | 1 448 1 194 21.26% | 1 071 |
|
Net income Million CHF | Released Forecast Spread | 559 724 -22.75% | 645 720 -10.44% | 869 844 2.92% | 2 944 1 376 113.89% | 1 215 1 046 16.18% | 884 |
|
EPS CHF | Released Forecast Spread | 7,48 9,47 -21.04% | 8,65 9,68 -10.66% | 11,6 11,6 0.61% | 39,5 18,9 108.65% | 16,3 14,1 16.05% | 12,3 |
| Announcement Date | 01/30/19 | 01/21/20 | 01/27/21 | 01/26/22 | 01/25/23 | - |
Quarterly results
| Fiscal Period | December | 2019 S1 | 2019 S2 | 2020 S1 | 2020 S2 | 2021 S1 | 2021 S2 | 2022 S1 | 2022 S2 | 2023 S1 | 2023 S2 | 2024 S1 | 2024 S2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Millones CHF | Released Forecast Spread | 2 976 2 977 -0.03% | 2 944 2 907 1.26% | 3 074 3 080 -0.2% | 3 111 3 086 0.8% | 2 542 2 474 2.74% | 2 867 2 650 8.18% | 2 982 2 965 0.58% | 3 241 3 201 1.25% | 3 078 3 168 -2.85% | 3 300 | 3 436 | 3 568 |
|
EBITDA Millones CHF | Released Forecast Spread | 828 771 7.39% | 796 783 1.66% | 893 848 5.36% | 835 813 2.72% | 847 778 8.91% | 818 813 0.63% | 987 930 6.11% | 1 008 984 2.49% | 922 933 -1.23% | 900 | 998 | 1 169 |
|
EBIT Millones CHF | Released Forecast Spread | 643 621 3.5% | 606 581 4.26% | 706 637 10.76% | 652 608 7.33% | 606 607 -0.12% | 545 613 -11.14% | 698 680 2.59% | 699 703 -0.6% | 563 619 -9.09% | 595 | ||
|
Earnings before Tax (EBT) Millones CHF | Released Forecast Spread | 442 467 -5.32% | 407 424 -4.03% | 564 479 17.87% | 422 467 -9.6% | 296 476 -37.81% | 464 525 -11.64% | 594 637 -6.81% | 854 667 28% | 486 556 -12.62% | 517 | ||
|
Net income Millones CHF | Released Forecast Spread | 299 377 -20.7% | 346 339 2.19% | 477 399 19.65% | 392 391 0.17% | 319 414 -23.01% | 2 625 2 466 6.45% | 492 539 -8.74% | 723 537 34.55% | 410 465 -11.88% | 433 | ||
|
EPS CHF | Released Forecast Spread | 4,01 5,08 -21.1% | 4,64 4,70 -1.17% | 6,39 5,35 19.38% | 5,24 5,16 1.58% | 4,28 5,50 -22.13% | 35,2 33,1 6.56% | 6,61 7,12 -7.21% | 9,73 7,19 35.28% | 5,54 6,21 -10.79% | 5,88 | ||
| Announcement Date | 24/07/19 | 21/01/20 | 24/07/20 | 27/01/21 | 23/07/21 | 26/01/22 | 22/07/22 | 25/01/23 | 21/07/23 | - | - | - |
More events
Past sector events for Lonza Group AG
| 2023-09-21 12:00 pm | ABIVAX SOCIÉTÉ ANONYME : Q2 2023 Earnings Release |
| 2023-09-21 01:00 am | VALNEVA SE : Q2 2023 Earnings Release |
| 2023-09-07 02:00 am | GENUS PLC : Q4 2023 Earnings Release |
| 2023-08-30 | BIDE PHARMATECH CO. : Q2 2023 Earnings Release |
| 2023-08-30 | GEMPHARMATECH CO. : Q2 2023 Earnings Release |
| 2023-08-30 | HINOVA PHARMACEUTICALS INC. : Q2 2023 Earnings Release |
| 2023-08-30 04:15 pm | ALVOTECH : Q2 2023 Earnings Release |
| 2023-08-29 | FORMYCON AG : Q2 2023 Earnings Release |
| 2023-08-29 | JOINN LABORATORIES(CHINA)CO. : Q2 2023 Earnings Release |
| 2023-08-29 02:00 am | PURETECH HEALTH PLC : Q2 2023 Earnings Release |
